TY - JOUR
T1 - Decreased muscular radionuclide uptake in Tc-99m MIBI scintigraphy during paralytic phase of thyrotoxic periodic paralysis
AU - Chang, Yung Yee
AU - Lan, Min Yu
AU - Wu, Hsiu Shan
AU - Huang, Shu Hua
AU - Chen, Shun Sheng
AU - Liu, Jia Shou
PY - 2008/4
Y1 - 2008/4
N2 - The underlying pathophysiology of thyrotoxic periodic paralysis (TPP) is still obscure. From histologic surveys, vacuole formation and abundant mitochondrial abnormalities ranged from swelling, matrical pallor, pleomorphism, and reduced cristae were often disclosed in the muscle fibers during paralytic periods. In a 47-year-old man experiencing 2 episodes of transient paralysis, hyperthyroidism with TPP was diagnosed. During the acute paralytic phase, a significant reduction of radionucleotide uptake in the quadriceps on Tc-99m sestamibi scintigraphy was found, aside from the previous morphologic findings, that it further suggests impaired mitochondrial integrity and cellular viability in TPP.
AB - The underlying pathophysiology of thyrotoxic periodic paralysis (TPP) is still obscure. From histologic surveys, vacuole formation and abundant mitochondrial abnormalities ranged from swelling, matrical pallor, pleomorphism, and reduced cristae were often disclosed in the muscle fibers during paralytic periods. In a 47-year-old man experiencing 2 episodes of transient paralysis, hyperthyroidism with TPP was diagnosed. During the acute paralytic phase, a significant reduction of radionucleotide uptake in the quadriceps on Tc-99m sestamibi scintigraphy was found, aside from the previous morphologic findings, that it further suggests impaired mitochondrial integrity and cellular viability in TPP.
KW - Mitochondrial abnormalities
KW - Tc-99m sestamibi scintigraphy
KW - Thyrotoxic periodic paralysis (TPP)
UR - http://www.scopus.com/inward/record.url?scp=41349108073&partnerID=8YFLogxK
U2 - 10.1097/RLU.0b013e3181662be7
DO - 10.1097/RLU.0b013e3181662be7
M3 - 文章
C2 - 18356677
AN - SCOPUS:41349108073
SN - 0363-9762
VL - 33
SP - 297
EP - 298
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
IS - 4
ER -